| Knowledge4COVID-19

Property	Value
is ?:annotates of	<https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0029244> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0039141> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0039142> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0041703> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0086418> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0086739> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0183789> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C0579142> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C5203670> <https://research.tib.eu/covid-19/entity/33746108_HAS_TOPIC_C5392141>
?:authorAffiliation	[\'RTI International, Berkeley, California. Electronic address: lynndee@rti.org.\', \'RTI International, Berkeley, California.\', \'University of Southern California, Keck School of Medicine, Los Angeles, California.\']
?:citedBy	-1
?:creator	<https://research.tib.eu/covid-19/entity/Bluthenthal_Ricky_N> <https://research.tib.eu/covid-19/entity/Kral_Alex_H> <https://research.tib.eu/covid-19/entity/Lambdin_Barrot_H> <https://research.tib.eu/covid-19/entity/Morris_Terry> <https://research.tib.eu/covid-19/entity/Ongais_Lee> <https://research.tib.eu/covid-19/entity/Wenger_Lynn_D>
?:doi	S1931-5244(21)00074-810.1016/j.trsl.2021.03.011
?:doi	<https://research.tib.eu/covid-19/entity/S1931-5244%2821%2900074-810.1016/j.trsl.2021.03.011>
?:hasPublicationType	<https://research.tib.eu/covid-19/entity/Journal_Article> <https://research.tib.eu/covid-19/entity/Research_Support%2C_N.I.H.%2C_Extramural>
?:journal	Translational research : the journal of laboratory and clinical medicine
is ?:pmid of	<https://research.tib.eu/covid-19/entity/33746108>
?:pmid	<https://research.tib.eu/covid-19/entity/33746108>
?:pmid	33746108
?:publication_isRelatedTo_Disease	<https://research.tib.eu/covid-19/entity/Covid-19>
?:rankingScore_SJR	-1.0
?:rankingScore_hIndex	-1
?:title	Ingenuity and resiliency of syringe service programs on the front lines of the opioid overdose and COVID-19 crises.
?:type	<https://research.tib.eu/covid-19/vocab/Publication> <https://research.tib.eu/covid-19/vocab/Publication_Author>
?:year	2021

Metadata

Anon_0

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://purl.org/net/provenance/ns#DataItem>

<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>

<http://www.w3.org/2004/03/trix/rdfg-1/Graph>

<http://xmlns.com/foaf/0.1/primaryTopic>

<https://research.tib.eu/covid-19/entity/33746108>

<http://xmlns.com/foaf/0.1/topic>

Anon_0

<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes>

<https://research.tib.eu/covid-19/data/entity/33746108>

<http://purl.org/net/provenance/ns#createdBy>

Anon_1 (more)

expand all